Highlights and Quick Summary
- Shareholders Equity (Other) for the quarter ending September 30, 2020 was $0 (a NaN% decrease compared to previous quarter)
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Other) of Design Therapeutics, Inc.
Most recent Shareholders Equity (Other)of DSGN including historical data for past 10 years.Interactive Chart of Shareholders Equity (Other) of Design Therapeutics, Inc.
Design Therapeutics, Inc. Shareholders Equity (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2020 | $0.0 | $0.0 | $0.0 | – | – |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology